Development and optimisation of hepatitis B recombinant antigen loaded chitosan nanoparticles as an adjuvant using the response surface methodology-Reference-Cited by-同舟云学术

Development and optimisation of hepatitis B recombinant antigen loaded chitosan nanoparticles as an adjuvant using the response surface methodology

Author:

Mehrabi Mohsen¹,Sadeghi‐Soureh Shima²,Mohammadpour Dounighi Naser³,Rezayat Seyed Mahdi⁴⁵,Doroud Delaram⁶,Khoobi Mehdi⁷,Amani Amir⁴

Affiliation:

1. Department of Medical NanotechnologySchool of MedicineShahroud University of Medical SciencesShahroudIran

2. Cellular and Molecular Research CenterCellular and Molecular Medicine InstituteUrmia University of Medical SciencesUrmiaIran

3. Razi Vaccine and Serum Research InstituteAgricultural Research, Education and Extension Organization (AREEO)KarajIran

4. Department of Medical NanotechnologySchool of Advanced Technologies in MedicineTehran University of Medical SciencesTehranIran

5. Department of PharmacologySchool of MedicineTehran University of Medical SciencesTehranIran

6. Regulatory DepartmentProduction and Research ComplexPasteur Institute of IranTehranIran

7. Biomaterials GroupThe Institute of Pharmaceutical Sciences (TIPS)Tehran University of Medical SciencesTehranIran

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Institution of Engineering and Technology (IET)

Subject

Condensed Matter Physics,General Materials Science,Biomedical Engineering,Bioengineering

Link

Reference37 articles.

3. Construction and production of Foxp3‐Fc (IgG) DNA vaccine/fusion protein;Niri N.M.;Avicenna. J. Med. Biotechnol.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献